Skip to content
stoqly
en

Popular

All languages

Figures come from SEC filings, which are in English. Company and industry names stay as filed.

$ USD

Popular

All currencies

Data is in US dollars, converted at the ECB reference rate of Oct 23, 2026.

Nano-X Imaging Ltd.

NNOX Nasdaq X-Ray Apparatus & Tubes & Related Irradiation Apparatus Financials FY2018โ€“FY2025

Revenue Total sales reported in the income statement.
$13.0M
15.4% vs prior year
Operating margin Operating income as a share of revenue.
โˆ’600.8%
97.9ย pts
Net income Profit after all expenses, interest and tax.
โˆ’$75.0M
Free cash flow Cash from operations minus capital spending.
โˆ’$45.0M
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
โˆ’65.9%
33.4ย pts
Market cap Last close times the latest diluted share count, so it is approximate.
โ€”
P/E Last close divided by diluted earnings per share over the last four quarters.
โ€”
On โˆ’$1.16 EPS (TTM)

What Nano-X Imaging Ltd. does

No business description yet.

Legal name
Nano-X Imaging Ltd.
Fiscal year ends
December 31, 2025
Latest annual report
20-F ยท Apr 30, 2026
Accession ยท CIK
0001213900-26-050191
0001795251

Revenue and margins

Nano-X Imaging Ltd. had $13.0M of revenue in fiscal 2025, up 15.4% on the year before.

Revenue
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was โˆ’$45.0M in fiscal 2025, โˆ’345.6% of revenue. Cash from operations minus capital spending.

Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Nano-X Imaging Ltd. returned โ€” to shareholders in fiscal 2025. The diluted share count rose 10.4%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Nano-X Imaging Ltd. can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $88.7M$77.6M$82.4M$57.7M$49.2M
Debt incl. finance leases $0.1M$3.5M$3.5M$6.1M$3.1M
Debt / equity 0.0x0.0x0.0x0.0x0.0x
Current ratio 1.8x3.3x5.7x5.6x4.0x
Quick ratio 1.8x3.3x5.6x5.5x3.8x
Total assets $363M$254M$219M$210M$162M
Total liabilities $71.0M$37.3M$23.1M$20.9M$22.4M
Shareholders' equity $292M$217M$196M$189M$140M
Net debt (โˆ’ = net cash) โˆ’$88.6Mโˆ’$74.1Mโˆ’$78.9Mโˆ’$51.6Mโˆ’$46.0M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โ€œPlanโ€ marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

โ€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8โ€“9 is strong, 0โ€“2 weak.

TestFY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive โœ• โœ• โœ• โœ• โœ• โœ• โœ• โœ•
Cash from operations is positive โœ• โœ• โœ• โœ• โœ• โœ• โœ• โœ•
Return on assets rose โ€” โ€” โœ“ โœ“ โœ• โœ“ โœ“ โœ•
Cash from operations exceeds net income โœ• โœ“ โœ“ โœ“ โœ“ โœ“ โœ“ โœ“
Debt fell relative to assets โ€” โ€” โ€” โ€” โœ• โœ• โœ• โœ“
Current ratio rose โ€” โ€” โœ“ โœ• โœ“ โœ“ โœ• โœ•
Share count didn't rise โ€” โœ• โœ• โ€” โ€” โœ“ โœ• โœ•
Gross margin rose โ€” โ€” โ€” โ€” โœ“ โœ“ โœ• โœ•
Revenue rose relative to assets โ€” โ€” โ€” โ€” โœ“ โœ“ โœ“ โœ“
F-score โ€” / 3โ€” / 4โ€” / 6โ€” / 54 / 86 / 93 / 93 / 9
Accruals ratio โ€”โˆ’143.5%โˆ’17.9%โˆ’7.9%โˆ’22.6%โˆ’6.8%โˆ’7.9%โˆ’18.4%
Altman Z'' โ€”โˆ’30.2548.412.631.144.373.91โˆ’3.70

8 years of figures

Amounts in USD. Hover a ratioโ€™s name for its definition.

Download CSV
Fiscal yearFY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue โ€” โ€” โ€” $1.3M $8.6M $9.9M $11.3M $13.0M
Gross profit โ€” โ€” โ€” โˆ’$1.5M โˆ’$6.9M โˆ’$6.6M โˆ’$10.6M โˆ’$12.8M
Research and development $0.7M $2.7M $9.2M $17.1M $26.5M $26.0M $20.2M $19.2M
Operating income โˆ’$1.9M โˆ’$22.6M โˆ’$43.9M โˆ’$61.6M โˆ’$118M โˆ’$62.6M โˆ’$56.7M โˆ’$78.2M
Pretax income โ€” โˆ’$22.6M โˆ’$43.8M โˆ’$61.8M โˆ’$117M โˆ’$61.1M โˆ’$53.9M โˆ’$76.8M
Income tax โ€” โ€” โ€” โˆ’$0.0M โˆ’$3.7M โˆ’$0.3M โˆ’$0.4M โˆ’$1.8M
Net income โˆ’$1.9M โˆ’$22.6M โˆ’$43.8M โˆ’$61.8M โˆ’$113M โˆ’$60.8M โˆ’$53.5M โˆ’$75.0M
Net income to common โ€” $22.6M $43.8M $61.8M $113M โ€” โ€” โ€”
Diluted EPS โˆ’$0.09 โˆ’$0.90 โˆ’$1.23 โˆ’$1.28 โˆ’$2.17 โˆ’$1.08 โˆ’$0.91 โˆ’$1.16
Diluted shares 0.02B 0.03B 0.04B โ€” 0.05B 0.00B 0.00B 0.00B
Cash flow
Cash from operations โˆ’$3.7M โˆ’$5.5M โˆ’$21.6M โˆ’$38.1M โˆ’$43.4M โˆ’$44.8M โˆ’$36.6M โˆ’$40.8M
Capital expenditure $0.1M $0.1M $13.9M $23.2M $7.2M $3.3M $2.8M $4.2M
Free cash flow โˆ’$3.7M โˆ’$5.6M โˆ’$35.5M โˆ’$61.2M โˆ’$50.6M โˆ’$48.1M โˆ’$39.4M โˆ’$45.0M
Depreciation and amortization $0.0M $0.1M $0.2M $0.5M $0.9M $1.2M $1.1M $1.2M
Stock-based compensation $0.1M $16.2M $24.8M $18.8M $18.6M $6.8M $7.3M $4.2M
Acquisitions โ€” โ€” โ€” $2.9M โ€” โ€” โ€” $0.2M
Balance sheet
Cash and short-term investments $0.0M $8.1M $213M $88.7M $77.6M $82.4M $57.7M $49.2M
Total debt โ€” โ€” โ€” $0.1M $3.5M $3.5M $6.1M $3.1M
Current assets โ€” $9.6M $220M $94.9M $82.5M $88.6M $78.7M $66.8M
Current liabilities โ€” $20.3M $4.5M $52.8M $25.1M $15.5M $14.0M $16.9M
Inventory โ€” โ€” โ€” $0.1M โ€” $2.4M $1.5M $3.1M
Property and equipment, net โ€” $0.2M $14.0M $37.4M $43.5M $42.3M $45.4M $29.7M
Goodwill โ€” โ€” โ€” $58.3M $7.4M โ€” โ€” $0.3M
Intangible assets โ€” โ€” โ€” $102M $91.2M $80.6M $70.0M $59.9M
Total assets โ€” $11.9M $236M $363M $254M $219M $210M $162M
Total liabilities โ€” $20.6M $5.4M $71.0M $37.3M $23.1M $20.9M $22.4M
Shareholders' equity โˆ’$6.4M โˆ’$8.8M $231M $292M $217M $196M $189M $140M
Margins
Gross margin โ€” โ€” โ€” โˆ’116.0% โˆ’80.2% โˆ’66.6% โˆ’94.0% โˆ’98.2%
Operating margin โ€” โ€” โ€” โˆ’4,720.7% โˆ’1,372.2% โˆ’631.9% โˆ’502.9% โˆ’600.8%
EBITDA margin โ€” โ€” โ€” โˆ’4,680.5% โˆ’1,361.7% โˆ’619.8% โˆ’493.0% โˆ’591.7%
Net margin โ€” โ€” โ€” โˆ’4,739.1% โˆ’1,320.2% โˆ’613.6% โˆ’474.3% โˆ’576.1%
FCF margin โ€” โ€” โ€” โˆ’4,694.7% โˆ’589.4% โˆ’485.4% โˆ’348.9% โˆ’345.6%
Returns
Return on capital โ€” โ€” โ€” โˆ’23.9% โˆ’65.2% โˆ’42.4% โˆ’32.6% โˆ’65.9%
Return on capital employed โ€” 269.0% โˆ’19.0% โˆ’19.8% โˆ’51.4% โˆ’30.8% โˆ’28.9% โˆ’53.9%
Return on equity โ€” โ€” โˆ’39.5% โˆ’23.6% โˆ’44.5% โˆ’29.5% โˆ’27.8% โˆ’45.6%
Return on assets โ€” โˆ’190.1% โˆ’35.3% โˆ’20.6% โˆ’36.7% โˆ’25.7% โˆ’25.0% โˆ’40.3%
Return on tangible equity โ€” โ€” 19.0% 46.8% 95.9% โˆ’52.9% โˆ’44.9% โˆ’94.3%
Growth
Revenue growth โ€” โ€” โ€” โ€” 557.8% 15.5% 13.9% 15.4%
Share count change โ€” 21.1% 41.6% โ€” โ€” โˆ’99.9% 4.1% 10.4%
Financial health
Debt / equity โ€” โ€” โ€” 0.0x 0.0x 0.0x 0.0x 0.0x
Current ratio โ€” 0.5x 49.1x 1.8x 3.3x 5.7x 5.6x 4.0x
Quick ratio โ€” 0.5x 49.1x 1.8x 3.3x 5.6x 5.5x 3.8x
Capital allocation
Capex / revenue โ€” โ€” โ€” 1,775.9% 83.6% 33.3% 24.5% 32.3%
Stock comp / revenue โ€” โ€” โ€” 1,442.2% 217.1% 69.0% 64.4% 32.2%
Quality scores
Piotroski F-score โ€” โ€” โ€” โ€” 4.0 6.0 3.0 3.0
Altman Z'' โ€” โˆ’30.2 48.4 2.6 1.1 4.4 3.9 โˆ’3.7
Accruals ratio โ€” โˆ’143.5% โˆ’17.9% โˆ’7.9% โˆ’22.6% โˆ’6.8% โˆ’7.9% โˆ’18.4%

Source: SEC EDGAR XBRL filings (CIK 0001795251). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ€” not investment advice. Check the original filings before relying on any figure.

โ†‘ โ†“ to move ยท โ†ต to open